DICYNONE

This brand name is authorized in Cyprus, Ecuador, Estonia, France, Lithuania, Mexico, Singapore, Tunisia.

Active ingredients

The drug DICYNONE contains one active pharmaceutical ingredient (API):

1	Etamsylate UNII 24YL531VOH - ETHAMSYLATE
	Etamsylate is a synthetic antihaemorrhagic and angioprotective drug acting on the first step of haemostasis (endothelium-platelet interaction). By improving platelet adhesiveness and restoring capillary resistance, it is able to reduce bleeding time and blood losses.
	Read more about Etamsylate

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
DICYNONE 500 Tablet	MPI, EU: SmPC	Υπουργείο Υγείας (CY)
DICYNONE 250 Solution for injection	MPI, EU: SmPC	Υπουργείο Υγείας (CY)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
B02BX01	Etamsylate	B Blood and blood forming organs → B02 Antihemorrhagics → B02B Vitamin K and other hemostatics → B02BX Other systemic hemostatics
Discover more medicines within B02BX01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	2661-MEE-0417, 29189-02-10
EE	Ravimiamet	1092147
FR	Base de données publique des médicaments	62904574, 63619119, 65312567
LT	Valstybinė vaistų kontrolės tarnyba	1006934, 1007139
MX	Comisión Federal para la Protección contra Riesgos Sanitarios	021M2000, 142M99, 212M
SG	Health Sciences Authority	00204P, 00279P
TN	Direction de la Pharmacie et du Médicament	20723011, 20723012, 20723013